• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Voltaren Ophthalmic (diclofenac sodium ophthalmic solution)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

September 2012

Summary View

PRECAUTIONS

  • add..... eye pain

ADVERSE REACTIONS

  • add..... eye pain

 

 

April 2011

Summary View

 

PRECAUTIONS

Nursing Women
  • Subsection revised

 

ADVERSE REACTIONS

  • Ocular subsection revised